부정맥 3 Debaste 2. 08:30~10:00: 4 회의장

Similar documents
The EP Perspective: Should We Do Hybrid Ablation, and Who Should We Do It On?

Surgical AF Ablation : Lesion Sets and Energy Sources. What are the data? Steven F Bolling, MD Cardiac Surgery University of Michigan

Should Paroxysmal Atrial Fibrillation be Treated During Cardiac Surgery?

Stand alone maze: when and how?

AATS STARS Meeting Miami Beach November 17, 2017

Surgical Ablation of Atrial Fibrillation. Gregory D. Rushing, MD. Assistant Professor, Division of Cardiac Surgery

What s New in the Guidelines for Surgical Ablation for Atrial Fibrillation?

New Guidelines: Surgical Ablation of Atrial Fibrillation. Niv Ad, MD

Antithrombotic Therapy in Patients with Atrial Fibrillation

Surgical Ablation: Which Lesion Set for Which Patient?

Surgical Ablation for Lone AF: What have we learned after 30 years?

The Journal of Thoracic and Cardiovascular Surgery

Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro

SURGICAL ABLATION OF ATRIAL FIBRILLATION DURING MITRAL VALVE SURGERY THE CARDIOTHORACIC SURGICAL TRIALS NETWORK

Clinical Practice Guidelines and the Under Treatment of Concomitant AF Vinay Badhwar, MD

Atrial fibrillation and advanced age

AF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT

Definition of Success and Surgical Results That Shouldn t Be a Hard Talk, Right?

AF Ablation in 2015 Why, Who, What and How? Steve Wilton ACC Rockies, Banff March 10, 2015

Recurrent Stroke under Anticoagulation in Mild MS & AF

What is Minimally Invasive Surgical Ablation?

Trial design and selection criteria

AF ABLATION Concepts and Techniques

ABLATION OF CHRONIC AF

Atrial Fibrillation Procedures Data Summary. Participant STS Period Ending 12/31/2016

Hybrid Ablation of AF in the Operating Room: Is There a Need? MAZE III Procedure. Spectrum of Atrial Fibrillation

Linear Ablation Should Not Be a Standard Part of Ablation in Persistent AF. Disclosures. LA Ablation vs. Segmental Ostial Ablation With PVI for PAF

Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes

Indicator Mild Moderate Severe

Hybrid Surgical Ablation in South America: Lesson Learned. Joao R. Breda

Κατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ.

Atrial Fibrillation: Catheter Ablation with New Technologies, Improving Quality of Life and Outcomes in Various Disease States

Surgical thermoablation of atrial fibrillation: Epicardial

Catheter Ablation of Atrial Fibrillation Persistent Atrial Fibrillation Catheter Ablation : where are we?

20% 10/9/2018. Fluoroless Ablation relinquishing an old habit. Prevalence of Atrial Fibrillation. Atrial Fibrillation is a Progressive Disease

Catheter Ablation of Atrial Fibrillation in Patients with Prosthetic Mitral Valve

Recent observations have focused attention on the PVs as a source of ectopic activity i determining i AF

Consensus document: Screening and Prevention of Atrial Fibrillation

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Biatrial Maze or PVI to Ablate Afib? Marc Gillinov, MD

Atrial Fibrillation Ablation: in Whom and How

Updates in Atrial Fibrillation

Should hybrid ablation be the standard of care instead of transcatheter ablation techniques?

In patients with an enlarged left atrium does left atrial size reduction improve maze surgery success?

Early Surgery in Asymptomatic Severe Aortic Stenosis Pros and Cons

심방세동과최신항응고요법 RACE II AFFIRM 항응고치료는왜중요한가? Rhythm control. Rate control. Anticoagulation 남기병 서울아산병원내과. Clinical Impact of Atrial Fibrillation

Catheter ablation of atrial fibrillation: Indications and tools for improvement of the success rate of the method. Konstantinos P.

Indicatie voor ablatie bij voorkamerfibrillatie. Andrea Sarkozy Cardiologie Universitair Ziekenhuis Antwerpen

Minimally Invasive Stand Alone Cox-Maze Procedure For Patients With Non-Paroxysmal Atrial Fibrillation

La terapia non anticoagulante nel paziente con FA secondo le Linee Guida F. CONROTTO

Postoperative Management of Patients Following Surgical Ablation

The problem with concomitant atrial fibrillation in non-mitral valve surgery

New Guidelines: Surgical Ablation of Atrial Fibrillation. Niv Ad, MD West Virginia University Washington Adventist Hospital

Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation

Dipen Shah Cardiology Service, University Hospitals, Geneva Switzerland

Predictors for permanent pacemaker implantation after concomitant surgical ablation for atrial fibrillation

In Whom and When Should Atrial Fibrillation Ablation be Considered?

Mitral Repair/AF Ablation Sternotomy Approach

Atrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology

Interventional solutions for atrial fibrillation in patients with heart failure

First question: Does CRT Work in AF?

Long-Term Atrial Fibrillation Progression: What We Know in 2014

Chronic Primary Mitral Regurgitation

MEDICAL POLICY I. POLICY

Conflicts of Interests

Atrial Fibrillation 2009

CATHETER ABLATION FOR ATRIAL FIBRILLATION WHEN and HOW

Left atrial Function In Echocardiography

Atrial Fibrillation Ablation in Patients with Heart Failure

Role of LAA isolation in AF cure

2018 CODING AND REIMBURSEMENT FOR. Cardiac Surgical Ablation and Left Atrial Appendage Management

How atrial fibrillation should be treated in the heart failure patient?

FDA Executive Summary. Prepared for the October 26, 2011 meeting of the Circulatory System Devices Panel

Innovations in AF Management

Outcomes of AF Ablation

Manuel Castellá Cardiovascular Surgery Hospital Clínic, Universidad de

Saudi Heart Association February 22, 2011

Manuel Castella MD PhD Hospital Clínic, University of

Atrial Fibrillation and Heart Failure: Rate vs. Rhythm Control Time for Re-evaluation

Atrial Fibrillation Surgery The Blackpool Experience

Controversies in Atrial Fibrillation and HF

Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco

Atrial Fibrillation Ablation in Patients with Heart Failure

30 Seconds is the Proper Endpoint for AF Ablation YES. Hugh Calkins MD. Professor of Medicine

Late secondary TR after left sided heart disease correction: is it predictibale and preventable

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands

Long-Term Outcome and Risks of Catheter Ablation for Atrial Fibrillation

The CHADS Score Role in Managing Anticoagulation After Surgical Ablation for Atrial Fibrillation

Atrial dysfunction and chronotropic incompetence

Overview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan

LEFT BUNDLE BRANCH BLOCK- BENIGN OR A HARBINGER OF HEART FAILURE? PROGNOSTIC INDICATOR?

Atrial Fibrillation and Sleep Apnea. Farhat S. Khairallah, MD, FHRS, FACC

The HISTORIC-AF TRIAL

Accepted Manuscript. What Can We Learn From a Novel Global Positioning System in Persistent Atrial Fibrillation? Kenton Zehr, M.D.

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Catheter Ablation of Arrhythmias: Are the Results Different in the Elderly Patients?

EP WIRE on Management Preexcitation syndromes

Jay Simonson, MD, FACC, FHRS Medical Director, Cardiac Electrophysiology Park Nicollet Heart and Vascular Center

Fibrillation Atriale Paroxystique : ablation, résultats, complications

The maze procedure is covered for drug resistant atrial fibrillation or flutter. This procedure is subject to review.

Transcription:

부정맥 3 Debaste 2. 08:30~10:00: 4 회의장 130420 Sinus Node Dysfunction vs. Atrial Fibrillation 45 years old man, persistent AF, planned for MVR, LA 69mm, EF 70%: Does he need additional maze surgery? CON Hui-Nam Pak, MD, PhD. Division of Cardiology Yonsei University Health System

Concomitant Cox Maze IV with MVS Damiano et al. J Thorac CV Surg. 2011;141:113-21.

Clinical Outcome of Maze Operation Prasad et al. J Thorac CV Surg. 2003;126:1822-27. Ahlsson et al. Scand Cardiovasc J. 2012;46:212-8.

Clinical Outcome of Maze Operation Prasad et al. J Thorac CV Surg. 2003;126:1822-27. Cox J et al. J Thorac CV Surg. 1999;118:833-40. Risk+ Stroke+ OAC- Risk+ Stroke- OAC- Risk+ Stroke+ OAC+ Risk+ Stroke- OAC+ Risk- OAC+ maze

M/64. Severe MSR

s/p MVR, TAP, & maze

Function of LA 1. Conduit 2. Reservoir 3. Booster Pump Function of LAA 1. Protect coronary artery 2. Reservoir 3. Booster pump 4. Endocrine organ

Mechanisms of AF Electrical Remodeling Ion Channel Remodeling AF beget AF APD & CV AF initiator & AF driver Structural Remodeling Atrial dilatation Atrial Fibrosis Gap junctional remodeling Matrix Remodeling Autonomic Neural Remodeling

A Sirius red stain B α SMA C Cx43 D PAS stain 100 µm 100 µm 100 µm 100 µm E Sirius red stain F α SMA G Cx43 H PAS stain 20 µm 20 µm 20 µm 20 µm Park JH, Pak HN, et al. Cardiovasc Pathol. 2012;110(3):373-7.

HRS-EHRA-ECAS Expert Consensus Documents for Concomitant Surgical AF Ablation Calkins et al. Europace 2012 IIb: Usefulness/ efficacy is less well established by evidence/ opinion. Maybe considered

Six RCTs for Maze in Mitral Surgery Deneke et al. Eur Heart J. 2002;23:558-66. Schuetz et al. Eur J Cardiothorac Surg. 2003;24:475-80. Carols et al. Circulation 2005;112[suppl I]:I-20~25. Doukas et al. JAMA. 2005;294:2323-29. Blomstrom-Lundqvist et al. Eur Heart J. 2007;28:2902-2908. Chevalier et al. Arch Cardiovasc Dis. 2009;102:769-75.

Patient Characteristics Patient Age (yr) LAD (mm) EF (%) number maze+ maze- maze+ maze- maze+ maze- Deneke et al RF 15 vs 15 64.7 69.7 59.8 57.8 64 61 Shuetz et al MW 23 vs 19 64.6 70.2 54.9 53.9 62.8 54.3 Carols et al RF 42 vs 28 55.4 50.7 61.1 58.8 62.8 66.1 Duokas et al RF 45 vs 44 67.2 67 58 60 NA NA Blomstrom et al Cryo 30 vs 35 69.5 65.6 61 58 53.5 57 Chenvalier et al RF 22 vs 21 69.1 66.3 54.6 52.6 59.8 61.3 mean 56.3 65.1 64.9 58.2 56.0 60.6 59.9 SD 5.2 5.2 7.2 2.9 2.9 4.2 4.5

MVS Outcomes MVR ACC (min) Complication (%) maze+ maze- maze+ maze- maze+ maze- Deneke et al 100 100 NA NA NA NA Shuetz et al 66.67 36.8 99.6 74 NA NA Carols et al 69.1 96.5 67.5 47.1 NA NA Duokas et al 23 29 70 64 32.7 37.5 Blomstrom et al 30 20 87.4 84.4 38.2 11.4 Chenvalier et al 45.5 80.9 93 74 18.2 14.3 mean 55.7 60.5 83.5 68.7 29.7 21.1 SD 28.6 36.0 14.2 14.1 10.4 14.3

MVS Outcomes Pacemaker (%) Mortality (%) Maintain SR (%) maze+ maze- maze+ maze- maze+ maze- Deneke et al 6.7 6.7 NA NA 80 26.7 Shuetz et al 12.5 0 4.2 5.3 80 33.3 Carols et al 2.3 3.5 2.3 0 79.4 26.9 Duokas et al 4.4 9.1 6.1 8.3 44.4 4.5 Blomstrom et al 23.3 17.1 2.9 0 73.3 42.9 Chenvalier et al 22.7 9.5 4.5 0 95.2 33.3 mean 12.0 7.7 4.1 2.7 75.4 27.9 SD 9.2 5.9 1.5 3.9 16.8 12.9

RCT: Irrigation Tip RF Cox maze III in Mitral Surgery Carols et al. Circulation 2005;112[suppl I]:I-20~25.

RCT: Additional maze in mitral surgery SR rate Deneke et al. Eur Heart J. 2002;23:558-66.

RCT: Microwave in Open Heart Surg Schuetz et al. Eur J Cardiothorac Surg. 2003;24:475-80.

Mini-maze 6mo Outcome Edgerton et al. J Thorac CV Surg. 2009;138:109-114.

Outcome of Catheter Ablation Yonsei AF Ablation Cohort

Overall Current State AF (n= 14; 3.5 %) Redo -ABL (n=33; 8.3%) SR+ AAD (n=34; 8.6%) SR, no AAD (n=316; 79.6%) After 3 Mo CR (n=98; 24.7%) AF (n=52; 13.1%) SR+AAD (n=46; 11.6%) SR, no AAD (n=299; 75.3%) At 3 Mo ER (n=130; 32.7%) AF (n=50; 12.5%) SR+AAD (n=80; 20.2%) SR, no AAD (n=267; 67.3%) Pre-RFCA Overall inclusion, AAD resistant AF (n=397) Won HY, Pak HN, et al. Int J Cardiol. 2012;[In Press]

RCT: Additional maze in mitral surgery Deneke et al. Eur Heart J. 2002;23:558-66.

RCT: RF in Mitral Surgery Doukas et al. JAMA. 2005;294:2323-29.

AF Correction Surgery: STS Natl Cardiac Database N=67,389. Gammie et al. Ann Thoracic Surg. 2008;85:909-15.

AF Correction Surgery: STS Natl Cardiac Database N=67,389. Gammie et al. Ann Thoracic Surg. 2008;85:909-15.

Questions for maze in MV Surgery Survival Benefit? Reduce Stroke? LA size limitation? High requirement of pacemaker? Rhythm Follow-up Strategy (ACC/AHA/ESC guidelines)? Cost Benefit? NO YES Mean LAD 57mm NO YES NO Reasons for Stroke prevention Restoration of LA function? Concomitant appendage resection? Anticoagulation effect?

Pre-existing AF does not Worsen Survival of HF Framingham Heart Study Wang et al. Circulation 2003;107:2920-2925.

Take-Home Message Concomitant maze operation during mitral valve surgery might be beneficial in preventing stroke, but increases OP time and cost. Rhythm control in significantly dilated LA accompanies high risk of AF recurrence or sinus node dysfunction without restoring atrial function. Rate control strategy might be reasonable strategy in patients with longstanding persistent AF and giant atria.

Acknowledgement Moon Hyung Lee, MD,PhD. Boyoung Joung, MD,PhD. Jae Min Shim, MD. Jae Sun Um, MD. Jin Wi, MD. Hee Sun Moon, MD. Junbeum Park, MD. Chun Hwang, MD. Young-Hoon Kim, MD,PhD. Jiwang Rheu, BSc. Min Young Jo, BSc. Dukwoo Park, BSc. Soo Young Kim, RN. Gun Hee Lee, RN. Won Woo Ryu, RN. Ji Hye Ha, RN. Hee Kyoung Hwang, RN. Yong Hyun Yoon, PhD. Jae Hyung Park, PhD. Hang Sik Shin, PhD Hyesun Gong, BSc. Min Jin Choi, BSc.

부정맥 3 Debaste 2. 08:30~10:00: 4 회의장 130420 Rebuttal Hui-Nam Pak, MD, PhD. Division of Cardiology Yonsei University Health System

Minimally Invasive Maze Surgery Han et al. Circ Arrhyth EP. 2009;2:370-77.

Mini-maze 6mo Outcome Edgerton et al. J Thorac CV Surg. 2009;138:109-114.

Thoracoscopic Surgical Ablation Dallas Lesion Set Edgerton, Jackman et al. Heart Rhythm 2009;6:S64-S70.

Overall Current State AF (n= 14; 3.5 %) Redo -ABL (n=33; 8.3%) SR+ AAD (n=34; 8.6%) SR, no AAD (n=316; 79.6%) After 3 Mo CR (n=98; 24.7%) AF (n=52; 13.1%) SR+AAD (n=46; 11.6%) SR, no AAD (n=299; 75.3%) At 3 Mo ER (n=130; 32.7%) AF (n=50; 12.5%) SR+AAD (n=80; 20.2%) SR, no AAD (n=267; 67.3%) Pre-RFCA Overall inclusion, AAD resistant AF (n=397) Won HY, Pak HN, et al. Int J Cardiol. 2012;[In Press]

HRS-EHRA-ECAS Expert Consensus Documents for Surgical AF Ablation Calkins et al. Europace 2012